Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.42 |
| ▸ | AAK1 | Q2M2I8 | 4/20 | 0.37 |
| ▸ | PARP1 | P09874 | 5/20 | 0.35 |
| ▸ | CDC7 | O00311 | 4/20 | 0.31 |
| ▸ | PIM1 | P11309 | 4/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.31 |
| ▸ | CIT | O14578 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.31 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.31 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.31 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.31 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19488296 | 0.99 | SCN10A (0.43) | SCN10AAAK1PARP1CDC7PIM1 | |
| SCHEMBL10202371 | 0.85 | SCN10A (0.54) | SCN10AAAK1PARP1CDC7PIM1 | |
| SCHEMBL10202375 | 0.84 | SCN10A (0.55) | SCN10AAAK1PARP1CDC7PIM1 | |
| SCHEMBL19488471 | 0.81 | SCN10A (0.40) | SCN10AAAK1PARP1 | |
| SCHEMBL19488554 | 0.81 | SCN10A (0.40) | SCN10AAAK1 | |
| SCHEMBL10182683 | 0.80 | PARP1 (0.50) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL19488306 | 0.79 | SCN10A (0.39) | SCN10AAAK1CSNK2BCSNK2A1CSNK2A2 | |
| SCHEMBL19488771 | 0.79 | SCN10A (0.41) | SCN10AAAK1 | |
| SCHEMBL19488583 | 0.78 | SCN10A (0.39) | SCN10AAAK1PARP1CSNK2BCSNK2A1 | |
| SCHEMBL19488592 | 0.78 | SCN10A (0.41) | SCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2601188-B1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2017-10-18 | — | — | EP | disclosed |